drug protocol number

ARGX-113-2308

drug sponsor

Argenx BV

drug study

Efgartigimod IV

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase